Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar

Yosuke Ozawa, CEO of Epistra Inc., presented at the “10th Shonan iPark Regenerative Medicine Seminar,” hosted by Shonan Health Innovation Park (Shonan iPark). The seminar was held online (Zoom webinar) on June 3, 2026, under the theme “The Future of Regenerative Medicine Transformed by AI and Robotics.” Ozawa presented on implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.

Event Overview

The Shonan iPark Regenerative Medicine Seminar is a series hosted by Shonan Health Innovation Park, a hub bringing together pharmaceutical companies and suppliers, aimed at sharing challenges in the development and manufacturing of regenerative medicine and cell therapies to advance their social implementation. The 10th edition focused on manufacturing automation through robotics and the advancement of process development through AI.

• Name: 10th Shonan iPark Regenerative Medicine Seminar
• Date: Wednesday, June 3, 2026, 16:00–17:35
• Format: Online (Zoom webinar)
• Organizer: Shonan Health Innovation Park (Shonan iPark)
• Details: https://iparksaisei10.peatix.com/

The event was originally planned as a hybrid (in-person and online) format, but was changed to fully online in consideration of an approaching typhoon and its potential impact on transportation safety.

Seminar Content

The seminar explored automation of regenerative medicine process development through robotics and AI.

In the main presentations, Mr. Atsushi Inoue, General Manager of the Digital Process Innovation Division at Cellfa Bioscience Inc., and Mr. Kenjiro Adachi, Process Development Lead in the same division, introduced their company’s regenerative medicine process development and robot manufacturing technologies, and shared their current position and outlook for manufacturing automation using robotics.

Ozawa’s Presentation

Ozawa presented under the title “Transforming Regenerative Medicine Process Development with AI and Robotics: Implementation Cases and the Future We Aim For.” Cell manufacturing and process development in regenerative medicine face significant challenges in labor and time due to the complexity of processes and rigorous quality management requirements. The talk explained Epistra’s approach using AI and mathematical optimization to address these challenges, drawing on real-world implementation examples.

Panel Discussion

A closing talk session was held with four speakers. Ms. Shinobu Kuwae, Senior Advisor at Minaris Advanced Therapies Inc., served as moderator, joined by Mr. Atsushi Inoue and Mr. Kenjiro Adachi of Cellfa Bioscience, and Ozawa. Speakers representing pharmaceutical companies, suppliers, and AI applications discussed how to combine robotics and AI to advance regenerative medicine processes, examining both challenges and potential solutions.